- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana publishes March newsletter
Dignitana AB today publishes the March newsletter featuring recent expansion with GenesisCare in the United States, the 2020 Year End Report and answers to Shareholder Questions. To read the newsletter click here or visit Dignitana.com.
Dignitana Release - wkr0006.pdf
The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here.
Dignitana announces that as of 15 April 2021 the company will only provide press releases and interim reports in English. The company's annual reports will continue to be published in both Swedish and English.
Dignitana meddelar att bolaget från och med 15 april 2021 endast kommer att tillhandahålla pressmeddelanden och delårsrapporter på engelska. Bolagets årsredovisningar kommer även fortsättningsvis att publiceras på både svenska och engelska.
For More Information Contact
Melissa Bourestom, VP Corporate Communications email@example.com +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, firstname.lastname@example.org. Learn more at www.dignitana.se or www.dignicap.com.
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen
Dignitana hires Johan Johansson to Head Operations, Research and Development
Aktiespararna women’s event to feature Dignitana CEO Catarina Mård Löwenadler
Dignitana newsletter highlights growth and customer satisfaction